Antitumor activities with a recombinant endoglin-MIP3a/Fc fusion protein as a model antigen

被引：0
|
作者：
He, Z. [1 ]
Liu, S. [1 ]
Lu, Y. [1 ]
Huang, Y. [1 ]
Guo, J. [1 ]
Zheng, S. [1 ]
机构：
[1] Hainan Med Univ, Affiliated Hosp 1, Tumor Inst, Haikou, Hainan, Peoples R China
来源：
EUROPEAN JOURNAL OF IMMUNOLOGY | 2019年 / 49卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
P1671
引用
收藏
页码：1675 / 1676
页数：2
相关论文
共 50 条
  • [31] Antitumor activities of dFv-LDP-AE: An enediyne-energized fusion protein targeting tumor-associated antigen gelatinases
    Zhong, Gen-Shen
    Wu, Min-Na
    Guo, Xiao-Fang
    Zhang, Sheng-Hua
    Miao, Qing-Fang
    Zhen, Yong-Su
    ONCOLOGY REPORTS, 2012, 28 (04) : 1193 - 1199
  • [32] Increased antitumor activities of glypican-3-specific chimeric antigen receptor-modified T cells by coexpression of a soluble PD1-CH3 fusion protein
    Pan, Zeyan
    Di, Shengmeng
    Shi, Bizhi
    Jiang, Hua
    Shi, Zhimin
    Liu, Ying
    Wang, Yi
    Luo, Hong
    Yu, Min
    Wu, Xiuqi
    Li, Zonghai
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2018, 67 (10) : 1621 - 1634
  • [33] INHIBITION OF TCR SIGNALING BY RECOMBINANT ILT3FC PROTEIN
    Vlad, George
    Chang, Chi-Chao
    Liu, Zhuoru
    Li, Muyang
    Suciu-Foca, Nicole
    HUMAN IMMUNOLOGY, 2012, 73 : 130 - 130
  • [34] PATHOGENICITY AND IMMUNOGENICITY OF RECOMBINANT HUMAN RETINAL S-ANTIGEN FUSION PROTEIN
    KASP, E
    ROBERTS, AJ
    STANFORD, MR
    WHISTON, R
    DUMONDE, DC
    BANGA, JP
    CURRENT EYE RESEARCH, 1992, 11 : 113 - 117
  • [35] Studies to Prevent Degradation of Recombinant Fc-Fusion Protein Expressed in Mammalian Cell Line and Protein Characterization
    Chakrabarti, Sanjukta
    Barrow, Colin J.
    Kanwar, Rupinder K.
    Ramana, Venkata
    Kanwar, Jagat R.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2016, 17 (06):
  • [36] Prolonged activity of a recombinant factor VIII-Fc fusion protein in hemophilia A mice and dogs
    Dumont, Jennifer A.
    Liu, Tongyao
    Low, Susan C.
    Zhang, Xin
    Kamphaus, George
    Sakorafas, Paul
    Fraley, Cara
    Drager, Douglas
    Reidy, Thomas
    McCue, Justin
    Franck, Helen W. G.
    Merricks, Elizabeth P.
    Nichols, Timothy C.
    Bitonti, Alan J.
    Pierce, Glenn F.
    Jiang, Haiyan
    BLOOD, 2012, 119 (13) : 3024 - 3030
  • [37] Production of recombinant tumor necrosis factor receptor/Fc fusion protein by genetically manipulated chickens
    Kyogoku, Kenji
    Yoshida, Kazuhiro
    Watanabe, Hiroyuki
    Yamashita, Takashi
    Kawabe, Yoshinori
    Motono, Makoto
    Nishijima, Ken-ichi
    Kamihira, Masamichi
    Iijima, Shinji
    JOURNAL OF BIOSCIENCE AND BIOENGINEERING, 2008, 105 (05) : 454 - 459
  • [38] Managment of Deliveries in Carriers for Hemophila A and Low FVIII Levels with Recombinant FVIII Fc Fusion Protein
    Halimeh, Susan
    Rott, Hannelore
    Siebert, Manuela
    Kappert, Guenther
    BLOOD, 2017, 130
  • [39] Real Life Experience in Clinical Practice with Recombinant Coagulation FVIII-Fc Fusion Protein
    Alvarez Roman, Teresa
    Monzon Manzano, Elena
    Fernandez-Bello, Ihosvany
    Martin, Monica
    Rivas Pollmar, Maria Isabel
    Justo Sanz, Raul
    Garcia Barcenilla, Sara
    Acuna, Paula
    Cebanu, Tamara
    Canales, Miguel A.
    Butta, Nora
    Jimenez-Yuste, Victor
    BLOOD, 2019, 134
  • [40] Assessment of clotting activity of recombinant fix FC fusion protein in European hemophilia treatment centers
    Willemze, A.
    Sadeghi-Khomami, A.
    Sorskog, L.
    Wiken, M.
    Lethagen, S.
    HAEMOPHILIA, 2018, 24 : 55 - 55
12345